UROLOGY OF VIRGINIA

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
http://www.urologyofva.net/
Clinical Trials
Related News

Liposomal Bupivacaine To Control Post-Operative Pain Following BMG

Phase 3
Completed
Conditions
Urethral Stricture
Interventions
Drug: Liposomal Bupivacaine
First Posted Date
2018-10-25
Last Posted Date
2021-10-01
Lead Sponsor
Urology of Virginia
Target Recruit Count
50
Registration Number
NCT03720223
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Drug: Degarelix acetate, Leuprolide acetate
First Posted Date
2011-04-29
Last Posted Date
2013-03-18
Lead Sponsor
Urology of Virginia
Target Recruit Count
50
Registration Number
NCT01344564
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)

First Posted Date
2006-01-10
Last Posted Date
2007-04-18
Lead Sponsor
Urology of Virginia
Target Recruit Count
60
Registration Number
NCT00274417
Locations
🇺🇸

Urology of Virginia, Virginia Beach, Virginia, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy